Background: Atrial fibrillation (Afib) that occurs after a successful atrial flutter (AFL) ablation may negate the potential benefits of the ablation. Afib occurs more often when severe left ...

In contrast to HF with reduced EF, where events (e.g., myocardial infarction) often signal the onset of cardiac dysfunction and symptoms, this is not the case in HF with normal EF, which starts ...

Focused cardiac ultrasonography is a point-of-care, qualitative or semiquantitative means of assessing cardiac size, structure, and function that is performed and interpreted by the clinician at the ...

The debate on the link between hypertension and systolic heart failure has been re-examined often and many such considerations are contained in pertinent reviews of the epidemiology, for example by ...

Please provide your email address to receive an email when new articles are posted on . Subclinical left ventricular abnormalities in SSc impact survival and increase dyspnea risk. LV ejection ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Women with HIV have a higher risk for several cardiac ...

Impact of Age and Primary Disease Site on Outcome in Women With Low-Grade Serous Carcinoma of the Ovary or Peritoneum: Results of a Large Single-Institution Registry of a Rare Tumor LVSD was frequent ...

Percutaneous coronary intervention (PCI) does not reduce all-cause mortality or heart failure hospitalization in patients with severe left ventricular dysfunction and extensive coronary artery disease ...

ENTRESTO The FDA has approved Entresto for the treatment of symptomatic heart failure with systemic left ventricular systolic dysfunction in pediatric patients aged 1 year and older. The Food and Drug ...

Cardiomyopathy is the leading cause of mortality in patients with DMD. Compared with their healthy counterparts, patients with DMD — including those with preserved left ventricular ejection fraction ...